(Q42164880)

17 October 2017

0 references

Angiotensin II and trials of cardiovascular outcomes (English)

1 reference

17 October 2017

1 reference

Peter Sleight

1

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

American Journal of Cardiology

17 October 2017

published in

1 reference

17 October 2017

volume

89

1 reference

17 October 2017

issue

2A

1 reference

17 October 2017

page(s)

11A-16A; discussion 16A-17A

1 reference

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902322-0

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902322-0

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902322-0

Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902322-0

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902322-0

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902322-0

From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902322-0

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902322-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(01)02322-0

1 reference

17 October 2017

1 reference